Abstract
Introduction

1
West Nile virus (WNV) belongs to the family Flaviviridae and is the etiological agent of West Nile fever and 2 West Nile encephalitis in horses and humans. WNV is classified phylogenetically into two major genetic lineages 3 (Lanciotti et al., 2002) . Recently, there are several reports that WNV can be grouped into five distinct genetic lineages 4 (Bondre et al., 2007; Zaayman, Human, and Venter, 2009) . In a mouse model of WNV neuroinvasion, the incidence 5 of encephalitis was associated with viral strains (Beasley et al., 2005) , and various molecular determinants of WNV 6 pathogenesis have been reported (Hasebe et al., 2010; Shirato et al., 2004a) .
7
The WNV genome consists of a positive-sense single-stranded RNA of approximately 11 kb, which encodes 8 three structural proteins (C, prM and E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B 9 and NS5). Subgenomic WNV replicon RNA, which lacks most of the sequence coding for the structural proteins,
10
has been reported to replicate efficiently in cells (Kobayashi et al., 2014; Scholle et al., 2004; Shi, Tilgner, and Lo, 11 2002) .
12
Reverse genetics systems facilitate investigation of many aspects of the life cycle and pathogenesis of viruses. In 13 many flavivirus reverse genetics systems, the full-length cDNA of the viral genome is cloned into a plasmid under 14 the transcriptional control of an appropriate promoter, and the synthesized viral RNAs produce infectious 15 recombinant viruses in susceptible cells (Pavitrakar et al., 2015; Pierson et al., 2005; Yamshchikov, Mishin, and 16 Cominelli, 2001a; Yamshchikov et al., 2001b) . However, establishment of a reverse genetics system for WNV has 17 been hampered by the instability of plasmids harboring WNV full-length cDNA during propagation in bacteria. This 18 instability is likely caused by the production of undesired proteins toxic to E. coli due to cryptic promoter activity of 19 WNV sequences (Pu et al., 2011; Zheng et al., 2016) . To overcome the genetic instability of flaviviral genomes in 20 bacteria, an in vitro ligation method, PCR-based protocol, infectious-subgenomic-amplicons method and systems 21 using a bacterial artificial chromosome vector have been developed for preparation of full-length flaviviral RNA 22 (Aubry et al., 2014; Maeda et al., 2009; Suzuki et al., 2007) .
23
Homologous recombination is a DNA repair mechanism, a feature of which is an exchange of DNA strands 24 between a pair of homologous duplex DNA sequences (Alberts et al., 2015) . Homologous recombination is a useful 25 means of inserting a particular DNA sequence into a specific genetic locus (Hall, Limaye, and Kulkarni, 2009 performed at the Biosafety Level-3 facility at Hokkaido University in accordance with institutional guidelines.
11
Plasmid construction
12
The region coding the structural proteins of the 6-LP and Eg101 strains was cloned into pCXSN, which was 13 generated from pCMV-myc (Clontech, Mountain View, CA, USA) by replacing the sequence of the myc tag with a 14 multicloning sequence containing sites for the restriction enzymes XhoI, SalI, and NotI (Kobayashi et al., 2013;  15 Kobayashi et al., 2016) . The resultant plasmids were named pCXSN-NY99CME and pCXSN-Eg101CME,
16
respectively. For the construction of the pCMV-WNrep-DsRed plasmid expressing WNV replicon RNA in 17 mammalian cells, the sequence of the SP6 promoter of pWNrep-DsRed (Maeda et al., 2008) was replaced with that 18 of the CMV promoter, and the hepatitis delta virus (HDV) ribozyme sequence for self-catalytic cleavage at its 5'-end 19 and a polyadenylation signal was fused to the 3'-end of the WNV genome.
21
Virus production
22
The DNA fragments encoding the structural proteins were amplified by PCR or excised from the 23 pCXSN-NY99CME plasmid using XhoI and NotI. The DNA fragments electrophoresed in agarose gel were stained 24 with a Gel Indicator Kit (BioDynamics Laboratory, Tokyo, Japan) to visualize the DNA and were purified with a 
27
To detect the WNV genome, the sequence coding for the structural protein of WNV was amplified 28 using GoTaq DNA polymerase (Promega) and a pair of primers (5'-AGTTCGCCTGTGTGAGCTGAC-3'
6
and 5'-CGTCCAAGCCTCCACATCATTG-3'). To confirm the sequence of the produced WNV, the 1 complete coding sequence was amplified using Platinum Taq polymerase (Thermo Fisher Scientific) and To apply homologous recombination to the production of recombinant WNV, we first constructed a DNA-based 4 replicon system (pCMV-WNrep-DsRed). As shown in Fig. 1A , the WNV replicon sequences were cloned into the 5 pUC19 plasmid under the transcriptional control of the CMV promoter, and the ribozyme sequence from HDV and 6 the polyA signal from SV40 were fused to the 3'-end of the WNV genome. In the replicon sequences, the DsRed 7 gene was replaced with WNV nucleotides sequence 190-2379, corresponding to the majority of the WNV C, prM 8 and E genes. Transfection of pCMV-WNrep-DsRed resulted in production of the DsRed protein (Fig. 1B) . These 9 results suggested that the DNA-based replicon produced the WNV replicon RNA.
10
To examine production of infectious WNV by homologous recombination, 293T cells were transfected with the 11 pCMV-WNrep-DsRed plasmid and the PCR product of the viral structural protein gene, which had overlapping 12 sequences at the 5'-end of the C gene and 3'-end of the E gene with the pCMV-WNrep-DsRed plasmid (Fig. 1C) . At 
24
To prevent the introduction of mutations due to PCR error, a DNA fragment comprising the whole structural 25 protein gene was prepared from the pCXSN-NY99CME plasmid by cutting with appropriate restriction enzymes.
26
The resultant fragment (RE fragment) contained additional recognition sequences for XhoI and Kozak sequences at 27 the 5'-end, and a stop codon and sequences for NotI at the 3'-end. The RE fragment and pCMV-WNrep-DsRed were 28 transfected directly into 293T cells. At 3 days post-transfection, the viral titer in the culture supernatant of cells transfected with both DNAs was 1,200 Pfu/mL, while no virus was detected in the culture supernatant of cells 1 transfected with only the RE fragment (Fig. 2D) . The culture supernatant of co-transfected cells was inoculated into 2 Vero cells, in which the WNV antigen was detected after 5 days (Fig. 2E) . These results indicated that recombinant 3 WNV could be produced using a DNA fragment excised from the plasmid by cutting with restriction enzymes.
4
The relationship between viral production and the length of the overlap region was next investigated. The DNA (Fig. 3) . This result indicated that viral 9 production by the homologous recombination method was dependent on the length of the overlap region. 
22
To assess the biological properties of the recombinant and the chimeric WNV, termed NY99-HR and 23 NY99-CMEEg101, respectively, its growth kinetics were compared with those of the parental NY99 and Eg101
24
strains. The viral titer of NY99-HR was similar to that of parental NY99 strain at all time points, with peak levels at 25 48 h post-infection (Fig. 4B) . The plaque size in monolayers of Vero cells infected with NY99-HR was identical to 26 that of monolayers infected with the parental NY99 strain (Fig. 4C) . The viral titer of NY99-CMEEg101 was lower 27 than that of the parental Eg101 and NY99 strains at 24 and 48 h post-inoculation (Fig. 4B) . The plaques in Vero cell 28 monolayers infected with NY99-CMEEg101 were identical in size to those of monolayers infected with the parental
9
Eg101 strain, but smaller than those of monolayers infected with the parental NY99 strain (Fig. 4C) . These results 1 indicated that NY99-HR had growth properties and plaque morphologies similar to those of the parental strain, while 2 NY99-CMEEg101 had growth properties different from those of the parental strains and produced plaques with 3 morphology similar to those generated by the Eg101 strains. 
1
In this study, we established a novel reverse genetics system using homologous recombination for production of 2 infectious WNV using homologous recombination. Since the system relied on cloning of full-length flavivirus cDNA 3 is hampered by genetic instability, various reverse genetics systems for flavivirus have been developed. Plasmids 4 containing the full-length flavivirus cDNA sequence are unstable in bacteria due to the presence of cryptic promoter 5 sequences within the 5'-UTR and the sequences coding for the E-NS1 proteins (Pu et al., 2011; Zheng et al., 2016) .
6
Futhermore, full-length flaviviral cDNA generated using a PCR-based protocol and infectious-subgenomic-amplions 7 method could contain mutations caused by PCR error. In our system, full-length flaviviral cDNA was divided into 8 the sequence coding for the structural protein and a replicon harboring homologous sequences. These constructs were 9 stable in bacteria and no mutation was detected in the recombinant WNV sequence. This system prevents production 10 of undesired, or toxic proteins in E. coli due to cryptic promoter activity in the WNV sequence. Furthermore, cloned 11 recombinant WNV could be produced by homologous recombination between the DNA-based replicon plasmid and 12 the DNA fragment of the structural proteins excised from the cloned plasmid. However, the viral titer in the culture 13 supernatant of the transfected 293T cells using our system was lower than that produced using a fusion PCR protocol 14 or infectious molecular clone protocol (Maeda et al., 2009; Pierson et al., 2005) , suggesting that the homologous 15 recombination rate to generate complete genome is not high. In our system, the rate of recombinant WNV production 16 depends on the length of the homologous sequence and the efficacy of homologous recombination in the cells.
17
Overexpression of a recombinase in mammalian cells has been reported to promote spontaneous homologous 18 recombination (Park, 1995; Stéphane Vispé, 1998) , and so may enhance the production of recombinant WNV in our 19 homologous recombination method.
20
Our system was applied to the production of chimeric WNV, the structural protein gene of which was from the 21 Eg101 strain, and the other genes from the NY99 strain. The NY99 and Eg101 strains have been reported to exhibit 
1
In conclusion, this paper reports development of a novel method that will facilitate further research on WNV 2 infection. This method can be applied for production of recombinant virus of other flaviviruses. Genetic modification 3 of the viral genome using this system enables to produce chimeric virus leading to identification of the virulence 4 determinants and intracellular dynamics of flaviviruses, and can be applied for discovery of novel antiviral agents. 
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